ES345972A1 - Un metodo para atenuar la virulencia de virus de rubeola sin perdida de antigenicidad. - Google Patents

Un metodo para atenuar la virulencia de virus de rubeola sin perdida de antigenicidad.

Info

Publication number
ES345972A1
ES345972A1 ES345972A ES345972A ES345972A1 ES 345972 A1 ES345972 A1 ES 345972A1 ES 345972 A ES345972 A ES 345972A ES 345972 A ES345972 A ES 345972A ES 345972 A1 ES345972 A1 ES 345972A1
Authority
ES
Spain
Prior art keywords
production
rubella virus
virus vaccine
attenuated live
live rubella
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES345972A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RIT RECH IND THERAPEUT
Original Assignee
RIT RECH IND THERAPEUT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10444820&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES345972(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by RIT RECH IND THERAPEUT filed Critical RIT RECH IND THERAPEUT
Publication of ES345972A1 publication Critical patent/ES345972A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/20—Rubella virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/36011—Togaviridae
    • C12N2770/36211—Rubivirus, e.g. rubella virus
    • C12N2770/36234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ES345972A 1966-10-21 1967-10-11 Un metodo para atenuar la virulencia de virus de rubeola sin perdida de antigenicidad. Expired ES345972A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB47399/66A GB1135987A (en) 1966-10-21 1966-10-21 Attenuated live rubella virus vaccine and method of production

Publications (1)

Publication Number Publication Date
ES345972A1 true ES345972A1 (es) 1968-12-01

Family

ID=10444820

Family Applications (1)

Application Number Title Priority Date Filing Date
ES345972A Expired ES345972A1 (es) 1966-10-21 1967-10-11 Un metodo para atenuar la virulencia de virus de rubeola sin perdida de antigenicidad.

Country Status (19)

Country Link
US (1) US3686394A (fr)
AT (1) AT279038B (fr)
BE (1) BE705342A (fr)
BR (1) BR6794003D0 (fr)
CA (1) CA956232A (fr)
CH (1) CH477553A (fr)
CY (1) CY635A (fr)
DE (1) DE1617775B1 (fr)
DK (1) DK121619B (fr)
ES (1) ES345972A1 (fr)
FI (1) FI43625B (fr)
FR (2) FR1548489A (fr)
GB (1) GB1135987A (fr)
IL (1) IL28696A (fr)
LU (1) LU54664A1 (fr)
NL (1) NL148799B (fr)
NO (1) NO125776B (fr)
SE (1) SE341451B (fr)
YU (1) YU31804B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2129777C3 (de) * 1971-06-16 1982-04-15 Takeda Chemical Industries, Ltd., Osaka Verfahren zur Herstellung eines stark ageschwächte Rötelviren enthaltenden Impfstoffes
FR2505657A1 (fr) * 1981-05-13 1982-11-19 Pasteur Institut Perfectionnements apportes aux agents de stabilisation de virus vivants pour la preparation de vaccins, et vaccins stabilises contenant lesdits agents de stabilisation
US8460680B2 (en) * 2009-04-24 2013-06-11 National Health Research Institutes Polyvalent chimeric rubella virus-based vaccines

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3401084A (en) * 1965-07-29 1968-09-10 Merck & Co Inc Rubella vaccine and its preparation

Also Published As

Publication number Publication date
FR7321M (fr) 1969-10-06
NL148799B (nl) 1976-03-15
LU54664A1 (fr) 1967-12-12
NO125776B (fr) 1972-10-30
DE1617775B1 (de) 1970-10-22
BE705342A (fr) 1968-03-01
FR1548489A (fr) 1968-12-06
FI43625B (fr) 1971-02-01
YU31804B (en) 1973-12-31
GB1135987A (en) 1968-12-11
YU203467A (en) 1973-06-30
AT279038B (de) 1970-02-25
CA956232A (en) 1974-10-15
IL28696A (en) 1971-12-29
CH477553A (fr) 1969-08-31
BR6794003D0 (pt) 1973-02-22
SE341451B (fr) 1971-12-27
US3686394A (en) 1972-08-22
DK121619B (da) 1971-11-08
NL6714223A (fr) 1968-04-22
CY635A (en) 1972-03-07

Similar Documents

Publication Publication Date Title
GR37511B (el) Μεθοδος δια την παρασκευην νεων υποκατεστημενων φαινυλοξεικων οξεων και εστερων τουτων.
FR1454634A (fr) Procédé de génération de fumée et générateur de fumée
GB960850A (en) Measles virus vaccine
ES345972A1 (es) Un metodo para atenuar la virulencia de virus de rubeola sin perdida de antigenicidad.
ES446637A1 (es) Procedimiento para la preparacion de vacunas acelulares.
AU413666B2 (en) Attentuated live rubella virus vaccine and method of production
AU2796167A (en) Attentuated live rubella virus vaccine and method of production
AU216361B2 (en) Poliomyelitis virus vaccine and method of producing thesame
GB1187036A (en) Methods of and Plants for Burning Cement.
AU264471B2 (en) Attenuated live rabies vaccine and method of preparing thesame
CA793277A (en) Attenuated live rabies vaccine and method of preparing the same
AU1668156A (en) Poliomyelitis virus vaccine and method of producing thesame
AU2539762A (en) Attenuated live rabies vaccine and method of preparing thesame
CA638405A (en) Method of heating and generating steam
AU285054B2 (en) Steam generator and method of operating thesame
AU4957764A (en) Steam generator and method of operating thesame
CA669118A (en) Production of poliomyelitis vaccine (living)
BE601852A (fr) Vaccin antipoliomyélitique et sa préparation
AU258793B2 (en) Improvements in or relating to vaccines containing inactivated poliomyelitis virus
LU53410A1 (fr) Nouvelles mousses phénoliques de stabilité thermique et d'auto-extinguibilité améliorées
Ingraham The Preparation, Properties, and in Vivo Behavior of an Artificial Radioactive Antigen
AU2034162A (en) Improvements in or relating to vaccines containing inactivated poliomyelitis virus
ES239963A1 (es) Un método para la produccion de vacunas apropiadas para su administracion por via oral a animales domésticos
DK82034C (da) Tværfeltsmagnetisk linsesystem for elektroner eller andre ladele partikler og med midst ét par polflader.
FR1164196A (fr) Perfectionnements relatifs à l'atténuation du virus rabique et à la préparation d'un vaccin antirabique